NCT04703231

Brief Summary

It is aimed to compare the ocular findings in patients with natural and surgical menopause.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Sep 2020

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 1, 2020

Completed
4 months until next milestone

First Submitted

Initial submission to the registry

January 1, 2021

Completed
10 days until next milestone

First Posted

Study publicly available on registry

January 11, 2021

Completed
1.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 23, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 23, 2022

Completed
Last Updated

April 18, 2022

Status Verified

April 1, 2022

Enrollment Period

1.6 years

First QC Date

January 1, 2021

Last Update Submit

April 15, 2022

Conditions

Keywords

menopauseEye diseaseMacular changes

Outcome Measures

Primary Outcomes (4)

  • Macular thickness measurement

    Macular thickness(micron) in both eyes will be measured by optical coherence tomography,

    3 months after menopause

  • Detecting lens opacities

    Lens opacities (Grade 1,2,3,4) will be measured by indirect biomicroscopy,

    3 months after menopause

  • Intraocular pressure measurement

    Intraocular pressures( mm Hg) will be measured and recorded with the applanation tonometry device.

    3 months after menopause

  • Comparison of all detected data

    All numerical data will be analyzed and compared with relevant statistical tests and the p value will be accepted as less than 0.05 to be considered a statistically significant difference.

    3 months after menopause

Study Arms (2)

Natural menopause(Control group)

Female patients between 45-60 years of age diagnosed with menopause without any intervention

Diagnostic Test: measurement of macular thickness, corneal thickness and lens opacities

Surgical Menopause (Case group)

Female patients aged 45-60 years included in the study 3 months after bilateral oophorectomy and hysterectomy

Diagnostic Test: measurement of macular thickness, corneal thickness and lens opacities

Interventions

The incidence of macular thickness, Corneal thickness, intraocular pressure and lens opacities will be investigated by an ophthalmologist.

Natural menopause(Control group)Surgical Menopause (Case group)

Eligibility Criteria

Age45 Years - 65 Years
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Will be studied in a patient population with low sociocultural level.

You may qualify if:

  • Newly diagnosed menopause (Natural or Surgical Menopause( At least 3 months after surgery),
  • No history of illness(Diabetes,Heart disease,Kidney disease etc.)
  • Not Smoking
  • Did not use alcohol
  • Have not use any medication
  • Age between 45-65 years
  • BMI between 20-25 kg/m

You may not qualify if:

  • Smoking or Alchohol consumption
  • Age before 45 and after 65 years
  • Have chronic disease
  • Using any medication
  • Have not diagnosed Menopause
  • BMI greater than 30 kg/m

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Batman Maternity and Child Health Hospital

Batman, 72000, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Eye Diseases

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER GOV
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principle investigator

Study Record Dates

First Submitted

January 1, 2021

First Posted

January 11, 2021

Study Start

September 1, 2020

Primary Completion

March 23, 2022

Study Completion

March 23, 2022

Last Updated

April 18, 2022

Record last verified: 2022-04

Data Sharing

IPD Sharing
Will not share

Locations